Humana Inc. (HUM)
245.91 USD -18.57 (-7.02%) Volume: 2.05M
Humana Inc.’s stock price stands at 245.91 USD, experiencing a 7.02% dip in this trading session with a trading volume of 2.05M. Despite the recent fluctuation, the stock presents a year-to-date percentage change of -3.07%, indicating a cautious market sentiment towards HUM.
Latest developments on Humana Inc.
Recent stock price movements of Humana Inc. (NYSE:HUM) have been influenced by various key events. The company disclosed $40,000 in lobbying expenditures, while Jump Financial LLC sold shares. Canada Pension Plan Investment Board decreased its holdings, while Dodge & Cox and Adams Wealth Management increased their positions. Additionally, various other entities such as Canada Life Assurance Co, Guggenheim Capital LLC, and Raymond James Financial Inc. made moves involving Humana stock. Despite an optimistic outlook on earnings by Zacks Research, the company’s shares were down by 2.9% recently. Humana also announced the results of its annual stockholders meeting and plans to issue a quarterly dividend of $0.89. These developments have contributed to the fluctuations in Humana Inc.’s stock price.
Humana Inc. on Smartkarma
Analysts on Smartkarma have been covering Humana Inc, a provider of Medicare Advantage plans to around 6 million members. Value Investors Club‘s report from Monday, Oct 28, 2024, leans bullish on the company, highlighting its focus on value-based care relationships with providers and cost-saving behaviors. On the other hand, Baptista Research suggests that Humana could be a potential acquisition target for Cigna, one of its rivals in the U.S. health insurance market. The report mentions informal talks between the two companies and how changes in government Medicare plan ratings have impacted Humana’s performance.
A look at Humana Inc. Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Humana Inc‘s overall outlook, as indicated by the Smartkarma Smart Scores, shows a positive trend for the company. With high scores in Value and Dividend, Humana Inc is seen as a strong investment option for those looking for stability and potential returns. The company’s Momentum score also suggests that it is performing well in terms of market performance and investor interest. While the Growth and Resilience scores are slightly lower, the overall outlook for Humana Inc remains promising.
As a managed health care company with a focus on coordinated health care services, Humana Inc has established itself as a key player in the industry. With a strong presence in the United States and Puerto Rico, the company serves a wide range of customers, including employer groups, government-sponsored plans, and individuals. By offering a variety of health care products and services, Humana Inc continues to demonstrate its commitment to providing quality care to its members while also delivering value to its shareholders.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
